Use Code: WF26 And Get 30% OFF, T&C Applay | Get Free Delivery With No Minimum Order

Frequently bought together
RIAXINE SYRUP 100ML
- Sku : I-005569
Key features
RIAXINE SYRUP 100ML is an oral solution containing bromhexine 0.8 mg/ml. It reduces mucus viscosity by depolymerizing mucopolysaccharide fibers and increasing serous bronchial secretions, thereby enhancing mucociliary clearance and expectoration. It is indicated for the symptomatic treatment of respiratory tract disorders associated with viscid mucus and productive cough, including acute and chronic bronchitis and other conditions with mucus retention. Available over the counter as a 100 ml oral solution.- Brand: RIAXINE
- Active Ingredient: BROMHEXINE 0.8mg/ml
- Strength: 0.8mg/ml
- Dosage Form: Oral solution
- Pack Size: 100 ml
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Respiratory
- Pharmacological Group: Cough & Cold Preparations
- Drug Class: Mucolytic/expectorant (bromhexine; benzylamine derivative; ATC R05CB02).
- Manufacturer: RIYADH PHARMA
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1301256590
- Shelf Life: 36 months
- Storage: store below 25°c
- Symptom Target: Cough
- Sedating: No
Frequently bought together
Indications
Approved Uses
Symptomatic treatment of respiratory tract disorders associated with viscid mucus and productive cough (e.g., acute/chronic bronchitis and other conditions with mucus retention).
Off-Label Uses
Adjunct to aid mucus clearance in conditions with tenacious secretions (e.g., bronchiectasis); use in cystic fibrosis has been described but is not a standard, guideline-preferred mucolytic strategy in many settings.
Dosage & Administration
Dosing by Condition
Productive Cough (Adults and children >12 years): 10ml (8mg) three times daily. Children 6-12 years: 5ml (4mg) three times daily. Children 2-5 years: 2.5ml (2mg) three times daily.
Initial Dose
Adults: 10 ml (8 mg) three times daily
Maintenance Dose
Adults: 10 ml (8 mg) two to three times daily
Maximum Dose
Adults: 16 mg three times daily (maximum 48 mg/day).
How to Take
Shake well before use; measure the dose with a calibrated measuring spoon/cup or oral syringe; may be taken with or without food; maintain adequate fluid intake to help mucus clearance.
Side Effects
Common Side Effects
Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal/epigastric pain), headache, dizziness; may rarely cause hypersensitivity reactions including rash/urticaria and very rarely severe cutaneous reactions.
Safety & Warnings
Contraindications
Hypersensitivity to bromhexine or any excipient.
Age Restriction
Not recommended in children under 2 years unless specifically prescribed/closely supervised by a physician; can be used from age ≥2 years with age-appropriate dosing.
Drug Interactions
Drug Interactions
May increase penetration of some antibiotics into bronchial secretions (e.g., amoxicillin, erythromycin, cefuroxime/other tetracyclines); avoid routine combination with antitussives (e.g., codeine, dextromethorphan) as it may impair mucus clearance.
Food Interaction
No restriction
Storage & Patient Advice
Missed Dose
Take as soon as remembered; skip if it is almost time for the next dose; do not double the dose
Overdose
Expected symptoms are mainly gastrointestinal (nausea, vomiting, diarrhea/abdominal discomfort, possible hypersalivation); management is supportive/symptomatic, consider decontamination if a large recent ingestion, and seek urgent medical advice/poison center guidance.
Patient Counseling
Shake well and measure doses accurately; drink plenty of fluids; avoid combining with cough suppressants unless advised; stop and seek medical care if rash/blistering or other hypersensitivity occurs; seek medical advice if symptoms persist/worsen or last ~5-7 days, or if fever/shortness of breath occurs.
Pharmacology
Mechanism of Action
Reduces mucus viscosity by depolymerizing mucopolysaccharide fibers and increasing serous bronchial secretions, thereby enhancing mucociliary clearance and expectoration.
Onset of Action
Some symptomatic effect may begin within hours, but clinically noticeable benefit is typically seen after 2-3 days of regular use.
Duration of Effect
Typically dosed 2-3 times daily; clinical mucus-thinning benefit is maintained over the dosing interval rather than a precisely defined single-dose duration.
Half-Life
Terminal elimination half-life is approximately 12 hours (with multi-compartment kinetics); ambroxol (active metabolite) has a longer half-life (often ~10 hours or more depending on source).
Bioavailability
Low absolute oral bioavailability (approximately 20-30%) due to significant first-pass metabolism.
Metabolism
Extensive hepatic first-pass metabolism; primarily via oxidative pathways (e.g., demethylation/hydroxylation) to metabolites including ambroxol (an active metabolite).
Excretion
Primarily renal excretion, mainly as metabolites (roughly 85-90% in urine), with a smaller fraction via feces.
Protein Binding
Highly protein bound, approximately 95%.
Product Information
Available Dosage Forms
Tablet, Syrup, Oral Solution, Inhalation Solution.
Composition per Dose
Each 5 ml: Bromhexine hydrochloride 4 mg (equivalent to 0.8 mg/ml)
Generic Availability
Yes
OTC Alternatives
Guaifenesin (expectorant), ambroxol (mucolytic), and N-acetylcysteine (mucolytic) where available OTC locally.
Symptom Target
Cough
Sedating
No
Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 23-08-2026
-1744229570.gif)















